BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Non-GAAP Adjusted Net Income (Loss) by Quarter
Non-GAAP Adjusted Net Income (Loss) ($M) ($M)
BeOne Medicines Non-GAAP Adjusted Net Income (Loss): $444M in Q2 2026, up 75.8% from a year earlier. That is the highest of the 10 quarters on record here.
Where the Q2 2026 figure comes from
“|| Adjusted net income | $ | 444,497 | $ | 252,822 | $ | 819,539 | $ | 388,959”
Source: Form 8-K (filed 2026-08-05) ↗
Reported in Form 8-K EX-99.1 Non-GAAP Reconciliation Tables.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Adjusted Net Income (Loss) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 444 | +75.8% | Form 8-K (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 375 | +175.5% | Form 8-K (filed 2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | 225 | +1,297.3% | Form 8-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 30, 2025 | 304 | +488.7% | Form 8-K (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 253 | +985.4% | Form 8-K (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 136 | -193.3% | Form 8-K (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | 16.1 | – | Form 8-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 30, 2024 | 51.6 | – | Form 8-K (filed 2025-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 23.3 | – | Form 8-K (filed 2025-08-06) ↗ |
| Q1 2024 | Mar 31, 2024 | -146 | – | Form 8-K (filed 2025-05-07) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Non-GAAP Adjusted Net Income (Loss) ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/adj-net-inc
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.